Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 21-30 of 56

Page
per page
  1. Phenylpiracetam
    A3722 Phenylpiracetam
    Summary: Nootropic derivative of piracetam
      ≥10.92 mg/mL
  2. Puromycin aminonucleoside
    A3740 Puromycin aminonucleoside
     1 Citation
    Summary: Aminonucleoside portion of the antibiotic puromycin
      ≥14.45 mg/mL
  3. Solasodine
    A3832 Solasodine
    Target: Antioxidants
    Summary: Neuroprotective antioxidant glycoalkaloid
  4. UNC2250
    B2060 UNC2250
    Summary: Mer inhibitor,potent and selective
      ≥22.05 mg/mL
  5. Phenformin HCl
    B1373 Phenformin HCl
     1 Citation
    Target: AMPK
    Summary: biguanidine drug with anti-diabetic activity
      ≥12.1 mg/mL
  6. L-Thyroxine
    B2107 L-Thyroxine
    Summary: Iodine containing hormone
      ≥27.35 mg/mL
  7. Benazepril HCl
    B2216 Benazepril HCl
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: angiotensin-converting enzyme (ACE) inhibitor
      ≥18.1 mg/mL
  8. Dorzolamide
    B1279 Dorzolamide
    Target: Carbonic Anhydrases
    Summary: Carbonic anhydrase inhibitor
      Soluble in DMSO
  9. Tranexamic Acid
    B1858 Tranexamic Acid
    Target: fibrinolysis
    Summary: competitive inhibitor of plasminogen activation
      insoluble in EtOH; insoluble in DMSO; ≥6.6 mg/mL
  10. Antipyrine
    B1886 Antipyrine
    Target: COX
    Summary: analgesic and antipyretic agent

Items 21-30 of 56

Page
per page
Relate Categories
Now Shopping by
  1. Category Others Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All